The Bacterial Protein Azurin Impairs Invasion and FAK/Src Signaling in P-Cadherin-Overexpressing Breast Cancer Cell Models

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Bernardes, Nuno ^a,b   Ribeiro, Ana Sofia ^b   Abreu, Sofia ^a   Mota, Bruna ^a   Matos, Rute G ^c   Arraiano, Cecilia M ^c   Seruca, Raquel ^b   Paredes, Joana ^b   Fialho, Arsenio M ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AZURIN; CADHERIN; FOCAL ADHESION KINASE; GELATINASE A; P CADHERIN; PROTEIN TYROSINE KINASE; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL ASSAY; CELL INVASION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INHIBITION KINETICS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE; ZYMOGRAPHY;

AZURIN; BACTERIAL PROTEINS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; ENZYME ACTIVATION; FEMALE; FOCAL ADHESION KINASE 1; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASE 2; MCF-7 CELLS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84880423678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069023     Document Type: Article

References (30)

1. Kessenbrock K, Plaks V, Werb Z, (2010) Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell 141: 52-67 doi:10.1016/j.cell.2010.03.015.
2. Zhao J, Guan J-L, (2009) Signal transduction by focal adhesion kinase in cancer. Cancer metastasis reviews 28: 35-49 doi:-10.1007/s10555-008-9165-4.
3. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, et al. (2012) Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochimica et biophysica acta 1826: 297-311 doi:10.1016/j.bbcan.2012.05.002.
4. Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, et al. (2005) P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clinical cancer research 11: 5869-5877 doi:--10.1158/1078-0432.CCR-05-0059.
5. Albergaria A, Ribeiro AS, Vieira AF, Sousa B, Nobre AR, et al. (2011) P-cadherin role in normal breast development and cancer. The International journal of developmental biology 55: 811-822 doi:10.1387/ijdb.113382aa.
6. Ribeiro A, Albergaria A, Sousa B, Correia A, Bracke M, et al. (2010) Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 29: 392-402 doi:10.1038/onc.2009.338.
7. Luo M, Guan JL, (2010) Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer letters 289: 127-139 doi:10.1016/j.canlet.2009.07.005.
8. Zaborina O, Dhiman N, Chen ML, Kostal J, Holder IA, et al. (2000) Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing: external-ATP- dependent, P2Z-receptor-mediated necrosis apoptosis. Microbiology 146: 2521-2530.
9. Yamada T, Goto M, Punj V, Zaborina O, Chen ML, et al. (2002) Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. PNAS 99: 14098-14103 doi:10.1073/pnas.222539699.
10. Yamada T, Hiraoka Y, Ikehata M, Kimbara K, Avner BS, et al. (2004) Apoptosis or growth arrest: modulation of tumor suppressor p53 specificity by bacterial redox protein azurin, Proc. PNAS 101: 4770-4775.
11. Punj V, Bhattacharyya S, Saint-dic D, Vasu C, Cunningham EA, et al. (2004) Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 23: 2367-2378.
12. Yamada T, Fialho AM, Punj V, Bratescu L, Gupta TK Das, et al. (2005) Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity. Cellular microbiology 7: 1418-1431 doi:-10.1111/j.1462-5822.2005.00567.x.
13. Taylor BN, Mehta RR, Yamada T, Lekmine F, Christov K, et al. (2009) Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer research 69: 537-546 doi:--10.1158/0008-5472.CAN-08-2932.
14. Yamada T, Mehta RR, Lekmine F, Christov K, King ML, et al. (2009) A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells. Molecular cancer therapeutics 8: 2947-2958 doi:--10.1158/1535-7163.MCT-09-0444.
15. Apiyo D, Wittung-Stafshede P, (2005) Unique complex between bacterial azurin and tumor-suppressor protein p53. Biochemical and Biophysical Research Communications 332: 965-968 doi:10.1016/j.bbrc.2005.05.038.
16. Chaudhari A, Mahfouz M, Fialho AM, Yamada T, Granja AT, et al. (2007) Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth. Biochemistry 46: 1799-1810 doi:10.1021/bi061661x.
17. Mehta RR, Yamada T, Taylor BN, Christov K, King ML, et al. (2011) A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt. Angiogenesis 14: 355-369 doi:---10.1007/s10456-011-9220-6.
18. Bracke ME, Van Larebeke N, Vyncke BM, Mareel MM, (1991) Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. British journal of cancer 63: 867-872.
19. Willmarth NE, Ethier SP, (2006) Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. The Journal of biological chemistry 281: 37728-37737 doi:10.1074/jbc.M606532200.
20. Paredes J, Stove C, Stove V, Milanezi F, Van Marck V, et al. (2004) P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer research 64: 8309-8317 doi:--10.1158/0008-5472.CAN-04-0795.
21. Van Marck V, Stove C, Van Den Bossche K, Stove V, Paredes J, et al. (2005) P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer research 65: 8774-8783 doi:--10.1158/0008-5472.CAN-04-4414.
22. Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, et al. (2012) P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. The Journal of pathology. doi:10.1002/path.4143.
23. De Wever O, Derycke L, Hendrix A, De Meerleer G, Godeau F, et al. (2007) Soluble cadherins as cancer biomarkers. Clinical & experimental metastasis 24: 685-697 doi:---10.1007/s10585-007-9104-8.
24. Noë V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, et al. (2001) Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. Journal of cell science 114: 111-118.
25. Mannello F, Tonti GA, Medda V, Pederzoli A, Sauter ER, (2008) Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer. Cancer science 99: 2160-2169 doi:-10.1111/j.1349-7006.2008.00921.x.
26. Hua H, Li M, Luo T, Yin Y, Jiang Y, (2011) Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cellular and molecular life sciences: CMLS 68: 3853-3868 doi:--10.1007/s00018-011-0763-x.
27. Shibata K, Kikkawa F, Nawa A, Thant AA, Naruse K, et al. (1998) Both Focal Adhesion Kinase and c-Ras Are Required for the Enhanced Matrix Metalloproteinase 9 Secretion by Fibronectin in Ovarian Cancer Cells Advances in Brief Both Focal Adhesion Kinase and c-Ras Are Required for the Enhanced Matrix Metalloproteinase 9. Cancer research 58: 900-903.
28. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, et al. (2003) Differential regulation of cell motility and invasion by FAK. The Journal of Cell Biology 160: 753-767 doi:10.1083/jcb.200212114.
29. Guarino M, (2010) Src signaling in cancer invasion. Journal of cellular physiology 223: 14-26 doi:10.1002/jcp.22011.
30. Zhang CC, Yan Z, Zhang Q, Kuszpit K, Zasadny K, et al. (2010) PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity. Clinical cancer research: an official journal of the American Association for Cancer Research 16: 5177-5188 doi:-10.1158/1078-0432.CCR-10-1343.